Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Kingsoft Trade Idea Update: Cloud Listing to Crystalize the Value

StubWorld: Kingsoft Not In the Cloud; CH Karnchang Tests New Lows

Kingsoft Cloud (金山云) Pre-IPO: The Leading Cloud Provider in China

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Event-Driven

<p>We highlight that the stub value of Kingsoft (3888 HK) reached a record low since the listing of its main subsidiary Beijing Kingsoft (A) (Office (WPS)). The Office (WPS) has been outperforming the A-share market by a big margin recently, thanks to the work-from-home trend due to the coronavirus outbreak. We think there is a 19.5% upside from Kingsoft's current share price and would go long Kingsoft. </p>

We highlight that the stub value of Kingsoft (3888 HK) reached a record low since the listing of its main subsidiary Beijing Kingsoft (A) (Office (WPS)). The Office (WPS) has been outperforming the A-share market by a big margin recently, thanks to the work-from-home trend due to the coronavirus outbreak. We think there is a 19.5% upside from Kingsoft's current share price and would go long Kingsoft. 

Kingsoft Stub Trade: Record Low Since Office Software Listing

Kingsoft Corp

Kingsoft Stub Trade: Record Low Since Office Software Listing